PMC:7094172 / 3235-3603
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T84 | 35-45 | GO:0065007 | denotes | modulation |
| T83 | 53-54 | PG_4 | denotes | N |
| T82 | 55-62 | PG_4;GO:0051259 | denotes | protein |
| T81 | 63-78 | GO:0051259 | denotes | oligomerization |
| T80 | 88-97 | CHEBI:36357;CHEBI:36357 | denotes | molecules |
| T79 | 122-126 | CHEBI:36044;CHEBI:36044 | denotes | drug |
| T78 | 158-161 | NCBITaxon:11886 | denotes | CoV |
| T77 | 162-171 | PG_4 | denotes | N protein |
| T76 | 205-211 | SO:0000417 | denotes | domain |
| T75 | 237-243 | SO:0000417 | denotes | domain |
| T74 | 261-268 | SO:0000417 | denotes | domains |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T21 | 55-62 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T22 | 164-171 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T23 | 286-289 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T12 | 213-216 | Disease | denotes | NTD | http://purl.obolibrary.org/obo/MONDO_0008449|http://purl.obolibrary.org/obo/MONDO_0018075 |
| T14 | 314-317 | Disease | denotes | NTD | http://purl.obolibrary.org/obo/MONDO_0008449|http://purl.obolibrary.org/obo/MONDO_0018075 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T21 | 101-102 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T22 | 175-184 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | organized |
| T23 | 343-344 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T36 | 55-62 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T37 | 88-97 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
| T38 | 112-126 | Chemical | denotes | antiviral drug | http://purl.obolibrary.org/obo/CHEBI_36044 |
| T39 | 112-121 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T40 | 122-126 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T41 | 164-171 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 55-78 | http://purl.obolibrary.org/obo/GO_0051259 | denotes | protein oligomerization |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T20 | 0-368 | Sentence | denotes | Several studies suggested that the modulation of CoV N protein oligomerization by small molecules is a feasible antiviral drug development strategy.18,19 The CoV N protein is organized into the N-terminal domain (NTD) and the C-terminal domain (CTD), with both domains participating in RNA binding.20,21 All CoV N-NTD structures are folded in a monomeric conformation. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 59 | 49-52 | Species | denotes | CoV | Tax:11118 |
| 60 | 158-161 | Species | denotes | CoV | Tax:11118 |
| 61 | 308-311 | Species | denotes | CoV | Tax:11118 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32105468-26691874-61929498 | 148-150 | 26691874 | denotes | 18 |
| 32105468-26868298-61929499 | 151-153 | 26868298 | denotes | 19 |
| 32105468-25105276-61929500 | 298-300 | 25105276 | denotes | 20 |
| 32105468-27344959-61929501 | 301-303 | 27344959 | denotes | 21 |